NTES-S
09999
JD HEALTH
06618
TRIP.COM-S
09961
JD-SW
09618
BILIBILI-W
09626
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -90.41%2.64M | 140.35%54.16M | 124.99%27.55M | -52.98%-134.22M | -126.43%-110.24M | 34.61%-87.74M | 57.85%-48.69M | 65.31%-134.17M | -73.23%-115.51M | -497.27%-386.79M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -161.25%-209K | -97.30%-292K | 22.33%-80K | 50.50%-148K | 54.22%-103K | 84.07%-299K | 79.69%-225K | -140.33%-1.88M | -1,188.37%-1.11M | 0.89%-781K |
Interest expense - adjustment | 22.31%11.27M | 23.15%20.06M | 23.94%9.21M | -12.34%16.29M | -27.54%7.43M | -40.60%18.58M | -40.50%10.26M | -16.66%31.28M | 13.52%17.24M | 217.62%37.53M |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 417.92%2.69M | 1,474.00%1.57M | -40.41%519K |
Impairment and provisions: | ---- | -118.20%-6M | ---- | 92.70%32.97M | 593.96%32.73M | -42.38%17.11M | -56.57%4.72M | -73.23%29.7M | 18,950.88%10.86M | 1,248.88%110.93M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | -80.82%2.2M | -58.61%1.95M | -45.20%11.45M | -17.80%4.72M | -50.61%20.89M | --5.74M | 414.40%42.3M |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --57K |
-Impairment of goodwill | ---- | ---- | ---- | 429,483.33%25.78M | --25.78M | --6K | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | -220.00%-6M | ---- | -11.60%5M | --5M | -35.76%5.66M | ---- | -87.16%8.8M | --5.12M | --68.57M |
Revaluation surplus: | ---- | -133.33%-2M | ---- | -0.30%6M | 55,455.56%10M | 175.25%6.02M | -99.74%18K | -143.29%-8M | -63.80%7.02M | -20.84%18.47M |
-Fair value of investment properties (increase) | ---- | -133.33%-2M | ---- | 0.00%6M | --10M | 175.00%6M | ---- | -143.42%-8M | -63.79%7M | -19.93%18.42M |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | 500.00%18K | 20.00%18K | -94.00%3K | -70.00%15K | -84.71%50K |
Asset sale loss (gain): | ---- | ---108K | ---329K | ---- | ---- | ---- | ---- | -101.79%-2.52M | ---5.65M | 497.35%140.63M |
-Loss (gain) from sale of subsidiary company | ---- | ---108K | ---329K | ---- | ---- | ---- | ---- | -104.02%-5.65M | ---5.65M | --140.63M |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.13M | ---- | ---- |
Depreciation and amortization: | 24.73%30.98M | -28.24%51.25M | -40.69%24.83M | -31.41%71.42M | -25.50%41.87M | -31.46%104.12M | -26.62%56.2M | -29.33%151.92M | -33.86%76.59M | 203.64%214.99M |
-Amortization of intangible assets | -34.44%238K | 42.43%1.01M | 0.55%363K | -9.13%707K | -12.59%361K | -24.90%778K | -34.65%413K | -23.82%1.04M | -7.87%632K | -3.27%1.36M |
Special items | 328.75%2.21M | 88.70%-879K | 81.59%-967K | -11.22%-7.78M | 17.04%-5.25M | 92.04%-7M | 84.91%-6.33M | -563.85%-87.85M | -2,597.32%-41.96M | -38.00%18.94M |
Operating profit before the change of operating capital | -22.14%46.89M | 850.70%116.19M | 355.49%60.22M | -130.47%-15.48M | -247.82%-23.57M | 369.75%50.8M | 131.29%15.94M | -112.19%-18.83M | -159.63%-50.95M | 245.84%154.44M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | 88.90%-825K | -144.06%-3.11M | -1,836.92%-7.43M | 812.64%7.05M | 115.17%428K | -104.76%-989K | -136.09%-2.82M | 300.79%20.79M | 26.97%7.82M | 222.73%5.19M |
Accounts receivable (increase)decrease | 429.50%7.36M | -50.29%10.13M | -87.29%1.39M | 566.56%20.38M | 261.15%10.93M | -131.55%-4.37M | -83.73%3.03M | 294.36%13.85M | 2,253.01%18.6M | -204.33%-7.13M |
Accounts payable increase (decrease) | -799.35%-12.99M | 104.61%798K | 107.42%1.86M | -131.50%-17.33M | -267.57%-25.04M | 91.50%-7.49M | 124.08%14.94M | -4,940.19%-88.04M | -129.98%-62.05M | 139.98%1.82M |
Cash from business operations | -27.83%40.44M | 2,408.06%124.01M | 250.41%56.03M | -114.16%-5.37M | -219.80%-37.25M | 152.54%37.95M | 135.91%31.09M | -146.81%-72.23M | -235.81%-86.58M | 261.33%154.32M |
Other taxs | ---- | --543K | --543K | ---- | ---- | 30.23%-3.03M | -417.29%-1.53M | -117.53%-4.34M | ---295K | 10.69%-2M |
Net cash from operations | -28.53%40.44M | 2,418.16%124.56M | 251.87%56.57M | -115.39%-5.37M | -225.98%-37.25M | 145.60%34.92M | 134.04%29.57M | -150.27%-76.58M | -236.27%-86.88M | 276.35%152.33M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 161.25%209K | 97.30%292K | -22.33%80K | -50.50%148K | -54.22%103K | -84.07%299K | -79.69%225K | 140.33%1.88M | 1,188.37%1.11M | -0.89%781K |
Decrease in deposits (increase) | 34.24%-459K | -121.14%-1.1M | -440.49%-698K | 42.81%5.21M | -86.63%205K | -78.72%3.65M | -47.43%1.53M | 676.06%17.13M | 525.07%2.92M | -113.61%-2.97M |
Purchase of fixed assets | -206.43%-11.29M | 9.45%-11.52M | 37.23%-3.69M | -229.80%-12.72M | -4,673.17%-5.87M | 55.45%-3.86M | 88.04%-123K | 89.38%-8.66M | 96.57%-1.03M | 25.83%-81.53M |
Purchase of intangible assets | ---- | ---351K | ---- | ---- | ---- | ---390K | ---- | ---- | ---- | 88.08%-982K |
Sale of subsidiaries | ---- | --740K | --735K | ---- | ---- | ---- | ---- | -100.03%-84K | ---84K | --321.47M |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 91.36%-5.27M |
Net cash from investment operations | -223.49%-11.54M | -62.12%-11.94M | 35.86%-3.57M | -2,345.85%-7.36M | -440.24%-5.56M | -102.93%-301K | -43.85%1.64M | -95.56%10.27M | 108.31%2.91M | 320.46%231.5M |
Net cash before financing | -45.49%28.89M | 984.33%112.62M | 223.80%53.01M | -136.78%-12.74M | -237.21%-42.81M | 152.21%34.62M | 137.16%31.2M | -117.27%-66.31M | -392.27%-83.96M | 694.76%383.83M |
Cash flow from financing activities | ||||||||||
New borrowing | -7.84%2.94M | -37.83%6.64M | -70.14%3.19M | -95.88%10.69M | -95.58%10.68M | 5,872.88%259.64M | 5,463.17%241.83M | -93.07%4.35M | -92.74%4.35M | -62.95%62.76M |
Refund | 41.59%-16.28M | -193.22%-50.31M | -147.80%-27.87M | 122.37%53.97M | 125.32%58.3M | -431.11%-241.29M | -795.60%-230.25M | 53.07%-45.43M | 8.07%-25.71M | 34.47%-96.82M |
Interest paid - financing | -22.31%-11.27M | -23.15%-20.06M | -23.94%-9.21M | 12.34%-16.29M | 27.54%-7.43M | 40.60%-18.58M | 40.50%-10.26M | 16.66%-31.28M | -122.98%-17.24M | -196.17%-37.53M |
Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 50.00%-6.94M |
Net cash from financing operations | 11.75%-43.3M | -4,382.87%-96.54M | -239.65%-49.06M | 103.46%2.25M | 215.32%35.13M | 51.53%-65.14M | 58.67%-30.47M | 34.65%-134.39M | -19.55%-73.71M | -4,088.96%-205.64M |
Effect of rate | -16.37%-199K | 66.04%-90K | 76.25%-171K | -117.70%-265K | -159.41%-720K | -70.74%1.5M | 130.41%1.21M | 416.06%5.12M | -1,415.21%-3.99M | 61.93%-1.62M |
Net Cash | -465.36%-14.41M | 253.46%16.08M | 151.33%3.94M | 65.65%-10.48M | -1,140.79%-7.68M | 84.80%-30.51M | 100.47%738K | -212.63%-200.7M | -378.89%-157.67M | 356.60%178.19M |
Begining period cash | 61.44%42.03M | -29.22%26.03M | -29.22%26.03M | -44.10%36.78M | -44.10%36.78M | -74.83%65.8M | -74.83%65.8M | 208.21%261.38M | 155.46%261.38M | -51.82%84.8M |
Cash at the end | -8.00%27.42M | 61.44%42.03M | 5.03%29.8M | -29.22%26.03M | -58.11%28.38M | -44.10%36.78M | -32.06%67.75M | -74.83%65.8M | 44.26%99.72M | 208.21%261.38M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.